Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
PGNX vs. ETF Alternatives
Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology. The Company develops products for the treatment of prostate cancer, opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
Other News & PR